Browse Category

NASDAQ:WGS News 16 December 2025 - 13 January 2026

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx Holdings Corp. (Nasdaq: WGS) stock pulled back sharply on Tuesday, Dec. 16, 2025, with shares trading down roughly 7% intraday near $140 after a prior close around $150.6. The day’s move featured a wide trading range (roughly $138.9 to $150.4)—a reminder that WGS has become one of the market’s more volatile “high-expectations” healthcare growth names. StockAnalysis+1 So what changed today—and what hasn’t changed? The short version: the tape got jumpy, forecasts stayed optimistic (mostly), and the debate around valuation vs. growth is still the main event. What happened to GeneDx stock today (Dec. 16, 2025)? By early afternoon New
16 December 2025

Stock Market Today

Banco Santander stock heads into Monday after Friday bounce as buyback and Webster deal loom

Banco Santander stock heads into Monday after Friday bounce as buyback and Webster deal loom

8 February 2026
Madrid, Feb 8, 2026, 00:17 CET — Market closed. Banco Santander, S.A. (SAN.MC) shares last closed up 1.85% at 10.66 euros in Madrid on Friday, as the bank heads into a week where capital decisions may drive the tape more than day-to-day trading flows. (Reuters) The rebound matters because Santander is trying to do two things at once: buy growth in the United States and keep cash coming back to shareholders. For bank investors, that mix can turn quickly if funding costs, equity dilution or regulatory demands shift. It also lands in a tight window for signals. Traders are watching
Go toTop